Curated Resources — Treatment for severe Progressive Multifocal Leukoencephalopathy after Tysabri

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

Recommended deep-dive

Treatment for severe Progressive Multifocal Leukoencephalopathy after Tysabri — Background & Analysis

In-depth context and analysis on this topic for researchers and advocates.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

MedlinePlus — Trusted Health Information

Reference: MedlinePlus — Trusted Health Information

Authoritative source for clinical, regulatory, and public-health background reading.